Senti BiosciencesSNTI

13F holders, Q2 2024 (June 30)
20holders −7
2new positions
10sold out
1famous investor
$0.88avg. 13F price*

At the end of Q2 2024, 20 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, down 7 from Q1 2024. 2 opened new positions and 10 sold out. The largest holders were 8VC GP I, LLC ($7.0M), NEA Management Company, LLC ($1.2M) and ARK Investment Management ($438K). One famous investor held it Cathie Wood (0.0% of ARK Investment Management's portfolio).

Company
Senti Biosciences Inc.
CUSIP
81726A100
Latest filing quarter
Q3 2025

History

Number of 13F holders

0102030 Q1 2024: 27Q1 2024Q2 2024: 20Q2 2024Q3 2024: 2Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions2$12K
Exits10$112K

All 13F filers, Q1 2024 → Q2 2024: 48,288 shares bought and 667,195 shares sold, net −618,907 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders

8VC GP I, LLC 8.67% No change 2,537,558 $7.0M
NEA Management Company, LLC 0.09% No change 4,426,151 $1.2M
ARK Investment Management 0.00% Reduce -2.8% 1,585,772 $438K
Vanguard Group Inc. 0.00% No change 707,052 $195K
Intel Corp 0.03% No change 595,665 $164K
Geode Capital Management, LLC 0.00% No change 245,590 $68K
Two Sigma Investments, LP 0.00% Reduce -25.5% 69,751 $19K
BlackRock Inc. 0.00% No change 40,052 $11K
State Street Corp. 0.00% No change 39,100 $11K
Northern Trust Corp. 0.00% No change 36,848 $10K
Susquehanna International Group, LLP 0.00% New 31,400 $9K
Allen Operations LLC 0.00% No change 21,443 $6K
Triatomic Management LP 0.13% Reduce -95.0% 15,493 $4K
Sanctuary Advisors, LLC 0.00% — 14,704 $4K
HRT Financial LP 0.00% New 12,513 $3K
Morgan Stanley 0.00% Add +237.3% 5,396 $1K
Tower Research Capital LLC (TRC) 0.00% Reduce -55.1% 3,823 $1K
Bank of America Corp. 0.00% Add +240.3% 820 $227
Wolverine Asset Management LLC 0.00% No change 800 $220
Toronto Dominion Bank 0.00% No change 37 $102

"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.